StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

Browse signals
UTHRBullishAnalyst Target Updateanalyst
High materiality7/10

Cantor Fitzgerald raises United Therapeutics price target to $850

Oct 26, 2026, 12:35 PM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

Bullish based on the substantial target increase and implied upside; analyst targets are opinions and do not establish a catalyst.

AI summary

What happened, with direct paths to the underlying reporting

Cantor Fitzgerald raised its UTHR target from $700 to $850. Against the cited $590.57 price, the new target implies about 44% upside.

  • Target raised from $700 to $850.
  • New target implies about 44% upside from the cited $590.57 price.

Key facts

  1. 01

    Target: $850

  2. 02

    Posted price: $590.57

  3. 03

    Analyst firm: Cantor Fitzgerald

  4. 04

    Analyst: Olivia Brayer Saunders

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.

Related signals

More source-backed signals connected by company or event